Authors >
Charles Bankhead
Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. His career spans more than 30 years, including a decade with Medical World News, a leading medical trade magazine of its time. He had a long and successful freelance career before joining ѻý in 2007. Charles graduated with honors from Texas Tech University, receiving a BA in journalism, and completed a master's degree in mass communication, with specialization in health communication, also at Texas Tech.
Latest from Charles Bankhead
<ѻý>OncoBriefs: Zalutumumab Misses Mark in H&N Cancerѻý>
SCOTTSDALE, Ariz. -- Chemoradiation plus the targeted agent zalutumumab failed to improve disease control or survival in patients with squamous cell head and neck cancer, a finding that leads this roundup of news from the Multidisciplinary Head and Neck Cancer Symposium.
Feb 22, 2014
<ѻý>OncoBlog: Driving the CAR to a Cancer Cure?ѻý>
Is immunotherapy with chimeric antigen receptor (CAR)-directed T cells the "next big thing" in oncology? Presentations and discussion at a recent conference suggest the technology has considerable promise -- but will it qualify as a breakthrough? OncoBlog is a blog by the Medpage Today staff for readers with an interest in oncology. This post comes from Charles Bankhead.
Dec 19, 2013
<ѻý>10 Questions: John P. Erwin, MDѻý>
What's the biggest barrier to practicing medicine today? That's just the first of 10 questions the ѻý staff is asking leading clinicians and researchers to get their personal views on their chosen profession. In this series we share their uncensored responses. Here, answers from John P. Erwin, MD, of Scott & White Healthcare in Temple, Texas.
Dec 04, 2013